GlobeImmune (GBIM)
OTHER OTC:GBIM
US Market
Holding GBIM?
Track your performance easily

GlobeImmune (GBIM) Financial Statements

21 Followers

GlobeImmune Financial Overview

GlobeImmune's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; GlobeImmune is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 16Dec 15Sep 15Jun 15Mar 15
Income Statement-
Total Revenue$ 942.75K$ 1.05M$ 2.94M$ 1.28M$ 1.19M
Gross Profit-$ 1.05M$ 2.94M$ 1.28M$ 1.19M
EBIT$ -862.21K$ -795.03K$ 893.60K$ -1.30M$ -1.56M
EBITDA$ -843.12K$ -775.48K$ 914.13K$ -1.24M$ -1.48M
Net Income Common Stockholders$ -862.21K$ -795.03K$ 893.60K$ -1.30M$ -1.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.69M$ 9.90M$ 11.30M$ 12.37M$ 14.36M
Total Assets$ 9.77M$ 11.51M$ 13.21M$ 13.54M$ 15.44M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -8.69M$ -9.90M$ -11.30M$ -12.37M$ -14.36M
Total Liabilities$ 7.62M$ 8.52M$ 9.46M$ 10.70M$ 11.35M
Stockholders Equity$ 2.15M$ 2.99M$ 3.75M$ 2.84M$ 4.10M
Cash Flow-
Free Cash Flow$ -1.21M$ -1.41M$ -1.31M$ -1.99M$ -2.46M
Operating Cash Flow$ -1.21M$ -1.41M$ -1.31M$ -1.98M$ -2.43M
Investing Cash Flow$ 0.00$ 13.67K$ 238.44K$ -10.21K$ -23.94K
Financing Cash Flow--$ 0.00$ 0.00$ 0.00
Currency in USD

GlobeImmune Earnings and Revenue History

GlobeImmune Debt to Assets

GlobeImmune Cash Flow

GlobeImmune Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis